News

TCTMD12h
App-Based Support Aids Weight Loss With Semaglutide, Studies Show
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
Healio14h
Tirzepatide bests semaglutide for weight loss in adults with obesity
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
Medical Dialogues4h
Semaglutide May Offer Early Heart Disease Protection in High-Risk Patients even before weight loss, finds study
Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...
News-Medical.Net on MSN1d
Tirzepatide outperforms semaglutide for weight loss in people without diabetes
A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
Battle of the weight loss blockbuster drugs: Zepbound beats Wegovy by nearly 50%
Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.
Verywell Health on MSN7h
Could Wegovy Cause Hair Loss?
People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...
GLP-1 Weight Loss Drugs Cut Alcohol Cravings By Two-Thirds
GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...
Weight-loss jabs for obese kids 'are effective and help prevent mealtime rows'
The National Institute for Health and Care Excellence (Nice) previously stopped its appraisal of semaglutide (Wegovy) for use ...